Community/Retail

This weekly video program highlights the latest in pharmacy news, product news, and more.

The recent school shooting in Oregon has sparked a familiar conversation about mental illness in the United States.

The FDA is considering expanding the use for a drug currently indicated as a chronic hepatitis C (HCV) treatment.

As you celebrate American Pharmacists Month, take a moment to reconnect with your mentor.

The increasing roles that pharmacists and their national associations are taking in mental health care are illustrated in a new document from the International Pharmaceutical Federation (FIP). "Focus on mental health: The contribution of the pharmacist" is to be published tomorrow on World Mental Health Day.

St. Louis College of Pharmacy is one of the oldest and largest pharmacy schools in the country.

A new Avalere Health study of the nation's growing long term care pharmacy sector - the most detailed analysis since Medicare Part D was implemented in 2006 - finds LTC pharmacies playing a greater role in seniors' clinical care as new health payment and delivery models such as Accountable Care Organizations (ACOs), bundled payments and value-based purchasing proliferate amid a rapidly changing healthcare marketplace

AbbVie is launching Voices of HS, a new global campaign to increase awareness and support for people who have hidradenitis suppurativa.

No OTC products for sale and few customers coming in with prescriptions to fill were 2 reasons why a pharmacy in California seemed suspicious.

The FDA's Office of Generic Drugs (OGD) will no longer require final printed labeling to approve Abbreviated New Drug Applications (ANDAs).

AkzoNobel's work in the area of product stewardship has been recognized with the 2015 European Responsible Care Award from the European Chemicals Industry Association.

Over my nearly 3 decades of pharmacy practice, I have worked with some of the greatest pharmacists never known.

While I'm far from being an expert in oncology, I strongly feel that anticancer treatments should be affordable.

The FDA has approved a new treatment combination of Gilead's ambrisentan (Letairis) with tadalafil to treat pulmonary arterial hypertension.

I have never met a pharmacist who intentionally set out to make an error.

Patients with heart failure (HF) are predisposed to falls for a variety of reasons.

Nick Gentile, Director of State Grassroots Advocacy and Political Action for ASHP, discusses different legislative issues generating buzz on the state level, including biosimilars.

Fred's has named John Foley as the Company's Executive Vice President of Store Operations, effective October 7, 2015.

The Cardinal Health Foundation has awarded 29 grants totaling $924,551 to help non-profit health care institutions across the country improve the effectiveness, efficiency and excellence of patient care.

Pharmacists should take some time to counsel patients on the pros and cons of each antidepressant to help them select the best regimen.

The Pharmacy Quality Alliance will join several other pharmacy organizations in co-hosting a one-day pharmacy quality ratings workshop for community pharmacists on November 9th, 2015.

Vidya Tangella, head of the Innovation Center of Excellence at UnitedHealth Group, discusses the digital health application Baby Blocks.

Roche has launched a new HbA1C test to identify diabetes risk and diagnose and monitor patients with diabetes.

Taking hypertension medications at bedtime can improve blood pressure control and reduce the risk of developing diabetes.

Pharmacists can lead by example by promoting the FDA's patient safety initiatives in their practice settings.

I chose pharmacy because I wanted to be a part of the health care team.

Nick Gentile, Director of State Grassroots Advocacy and Political Action for ASHP, discusses the current status of provider status movements on the state level.

If you read clinical trial results carefully, then you will find a pattern in the results for vitamins.

The Meijer Simply Give campaign held this fall generated more than $3 million for food pantries throughout the Midwest, making it the most successful campaign in the program's history.

The FDA has approved Alkermes' extended-release aripiprazole lauroxil injection (Aristada) for the treatment of schizophrenia in adults.